本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Adaptive Biotechnologies Corp

11.80
+0.32002.79%
盘后12.260.4555+3.86%16:47 EDT
成交量:101.87万
成交额:1,195.37万
市值:17.93亿
市盈率:-12.31
高:11.96
开:11.88
低:11.48
收:11.48
数据加载中...
2025/06/12

重要事件披露

Form 8-K - Current report
2025/05/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/01

重要事件披露

Form 8-K - Current report
2025/03/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/11

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]